Findings presented at the International VT Symposium and published simultaneously in Circulation. CARDIFF-BY-THE-SEA, Calif. and PHILADELPHIA, Oct. 10, 2025 /PRNewswire/ -- Field Medical, Inc. today announced that Circulation has published six-month outcomes from the Ventricular Catheter...
Hence then, the article about circulation publishes 6 month outcomes from first in human vcas trial of fieldforce pulsed field ablation system 82 freedom from vt vf recurrence and 98 reduction in burden was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Circulation Publishes 6-Month Outcomes from First-in-Human VCAS Trial of FieldForce™ Pulsed Field Ablation System: 82% Freedom from VT/VF Recurrence and 98% Reduction in Burden )
Also on site :
- Wall Street’s $1.5 trillion megabanks start reporting results this week — and Washington is paying attention
- U.S. Aluminum Prices Remain High After Novelis Fire Hit Supply Chain
- FADEL Unveils Next Chapter in AI Innovation with Agentic Automation on AWS Bedrock